Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020)
Research output: Contribution to journal › Comment/debate
1Citation
(Scopus)
Fingerprint
Dive into the research topics of 'Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020)'. Together they form a unique fingerprint.